Akebia Therapeutics, Inc. (AKBA): Shares Outstanding
265.42M
As of 2025-12-31
271.74M
As of 2026-06-30
+13.0%
3-year compound annual growth
+12.4%
5-year compound annual growth
+24.1%
10-year compound annual growth
| Period ended | Shares Outstanding | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 265.42M | +18.0% | 2026-02-26, Balance as of period end |
| 2024-12-31 | 224.85M | +15.6% | 2026-02-26, Balance as of period end |
| 2023-12-31 | 194.58M | +5.7% | 2025-03-13, Balance as of period end |
| 2022-12-31 | 184.14M | +4.0% | 2024-03-14, Balance as of period end |
| 2021-12-31 | 177.00M | +19.5% | 2023-08-28, Balance as of period end |
| 2020-12-31 | 148.07M | +21.7% | 2022-03-01, Balance as of period end |
| 2019-12-31 | 121.67M | +4.1% | 2021-02-25, Balance as of period end |
| 2018-12-31 | 116.89M | +145.5% | 2020-03-12, Balance as of period end |
| 2017-12-31 | 47.61M | +23.3% | 2019-03-26, Balance as of period end |
| 2016-12-31 | 38.62M | +25.9% | 2018-03-12, Balance as of period end |
| 2015-12-31 | 30.66M | n/c | 2017-03-06, Balance as of period end |
| 2014-12-31 | 20.37M | n/m | 2016-03-14, Balance as of period end |
| 2013-12-31 | 1.38M | n/a | 2015-03-04, Balance as of period end |